Interim analysis of an open-label randomized controlled trial evaluating nasal irrigations in non-hospitalized patients with coronavirus disease 2019

被引：30

作者：

Kimura, Kyle S. ^{[1
]}

Freeman, Michael H. ^{[1
]}

Wessinger, Bronson C. ^{[2
]}

Gupta, Veerain ^{[2
]}

Sheng, Quanhu ^{[3
]}

Huang, Li Ching ^{[3
]}

Von Wahlde, Kate ^{[1
]}

Das, Suman R. ^{[1
,4
]}

Chowdhury, Naweed I. ^{[1
]}

Turner, Justin H. ^{[1
]}

机构：

[1] Vanderbilt Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, 1215 21st Ave South,Suite 7209, Nashville, TN 37232 USA

[2] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA

[3] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA

[4] Vanderbilt Univ, Sch Med, Dept Med, Div Microbiol & Infect Dis, Nashville, TN 37212 USA

来源：

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY | 2020年 / 10卷 / 12期

关键词：

saline; coronavirus; COVID-19; irrigation; nasal;

D O I：

10.1002/alr.22703

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

引用

页码：1325 / 1328

页数：4

共 50 条

[11] Early Treatment of High-Risk Hospitalized Coronavirus Disease 2019 (COVID-19) Patients With a Combination of Interferon Beta-1b and Remdesivir: A Phase 2 Open-label Randomized Controlled Trial
Tam, Anthony Raymond
Zhang, Ricky Ruiqi
Lung, Kwok Cheung
Liu, Raymond
Leung, Ka Yi
Liu, Danlei
Fan, Yujing
Lu, Lu
Lam, Athene Hoi Ying
Chung, Tom Wai Hin
Yip, Cyril Chik Yan
Lo, Jenny
Wu, Alan Ka Lun
Lee, Rodney
Sin, Simon
Ng, Pauline Yeung
Chan, Wai Ming
Shum, Hoi Ping
Yan, Wing Wa
Chan, Jasper Fuk Woo
Cheng, Vincent Chi Chung
Lau, Chak Sing
Kai-Wang, Kelvin
Chan, Kwok Hung
Yuen, Kwok Yung
Hung, Ivan Fan Ngai
CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E216 - E226
[12] Huashi baidu granule in the treatment of pediatric patients with mild coronavirus disease 2019: A single-center, open-label, parallel-group randomized controlled clinical trial
Chen, Jiande
Tang, Qiuyu
Zhang, Baoqin
Yuan, Shuhua
Chen, Jia
Shen, Shiyu
Wang, Dong
Lin, Jilei
Dong, Hongliang
Yin, Yong
Gao, Jian
FRONTIERS IN PHARMACOLOGY, 2023, 14
[13] Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial
Sivapalasingam, Sumathi
Lederer, David J.
Bhore, Rafia
Hajizadeh, Negin
Criner, Gerard
Hosain, Romana
Mahmood, Adnan
Giannelou, Angeliki
Somersan-Karakaya, Selin
O'Brien, Meagan P.
Boyapati, Anita
Parrino, Janie
Musser, Bret J.
Labriola-Tompkins, Emily
Ramesh, Divya
Purcell, Lisa A.
Gulabani, Daya
Kampman, Wendy
Waldron, Alpana
Ng Gong, Michelle
Saggar, Suraj
Sperber, Steven J.
Menon, Vidya
Stein, David K.
Sobieszczyk, Magdalena E.
Park, William
Aberg, Judith A.
Brown, Samuel M.
Kosmicki, Jack A.
Horowitz, Julie E.
Ferreira, Manuel A.
Baras, Aris
Kowal, Bari
Thomas DiCioccio, A.
Akinlade, Bolanle
Nivens, Michael C.
Braunstein, Ned
Herman, Gary A.
Yancopoulos, George D.
Weinreich, David M.
CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E380 - E388
[14] Timing of corticosteroids in non-severe non-hospitalized COVID-19 patients: open-label, two-center, randomized controlled study (TICS-COV19 study)
Issak, Emad R.
Amin, Mariam M.
KOREAN JOURNAL OF INTERNAL MEDICINE, 2023, 38 (02) : 207 - 217
[15] METHYLENE BLUE FOR TREATMENT OF HOSPITALIZED COVID-19 PATIENTS: A RANDOMIZED, CONTROLLED, OPEN-LABEL CLINICAL TRIAL, PHASE 2
Hamidi-Alamdari, Daryoush
Hafizi-Lotfabadi, Saied
Bagheri-Moghaddam, Ahmad
Safari, Hossin
Mozdourian, Mahnaz
Javidarabshahi, Zahra
Peivandi-Yazdi, Arash
Ali-Zeraati, Abass
Sedaghat, Alireza
Poursadegh, Farid
Barazandeh-Ahmadabadi, Fatemeh
Agheli-Rad, Marzieh
Tavousi, Seyed M.
Vojouhi, Shohreh
Amini, Shahram
Amini, Mahnaz
Majid-Hosseini, Seyed
Tavanaee-Sani, Ashraf
Ghiabi, Amin
Nabavi-Mahalli, Shima
Morovatdar, Negar
Rajabi, Omid
Koliakos, George
REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2021, 73 (03): : 190 - 198
[16] NASAFYTOL® supplementation in adults hospitalized with COVID-19 infection: results from an exploratory open-label randomized controlled trial
Gerain, Jean
Uebelhoer, Melanie
Costes, Berenice
Herman, Julie
Pietri, Sandra
Donneau, Anne-Francoise
Monseur, Justine
Henrotin, Yves
FRONTIERS IN NUTRITION, 2023, 10
[17] Efficacy of Early Treatment With Favipiravir on Disease Progression Among High-Risk Patients With Coronavirus Disease 2019 (COVID-19): A Randomized, Open-Label Clinical Trial
Chuah, Chuan Huan
Chow, Ting Soo
Hor, Chee Peng
Cheng, Joo Thye
Ker, Hong Bee
Lee, Heng Gee
Lee, Kok Soon
Nordin, Noridah
Ng, Tiang Koi
Zaid, Masliza
Zaidan, Nor Zaila
Wahab, Suhaila Abdul
Adnan, Nurul Ashikin
Nordin, Noorlina
Tee, Tze Yuan
Ong, Su Miin
Chidambaram, Suresh Kumar
Mustafa, Mahiran
CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E432 - E439
[18] Baidu Jieduan granules, traditional Chinese medicine, in the treatment of moderate coronavirus disease-2019 (COVID-19): study protocol for an open-label, randomized controlled clinical trial
Zhang, Wen
Xie, Qin
Xu, Xiaoming
Sun, Shuting
Fan, Tian
Wu, Xinxin
Qu, Yao
Che, Jinhua
Huang, Tingrong
Li, Huacheng
Zheng, You
Jiang, Chao
Fang, Bangjiang
Zhou, Shuang
TRIALS, 2021, 22 (01)
[19] Baidu Jieduan granules, traditional Chinese medicine, in the treatment of moderate coronavirus disease-2019 (COVID-19): study protocol for an open-label, randomized controlled clinical trial
Wen Zhang
Qin Xie
Xiaoming Xu
Shuting Sun
Tian Fan
Xinxin Wu
Yao Qu
Jinhua Che
Tingrong Huang
Huacheng Li
You Zheng
Chao Jiang
Bangjiang Fang
Shuang Zhou
Trials, 22
[20] Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019-a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial
Zhang, Chi
Li, Jiawen
Wu, Zhao
Wang, He
Que, Chengli
Zhao, Hong
Wang, Guiqiang
TRIALS, 2020, 21 (01)

← 1 2 3 4 5 →